Baseline Cerebrospinal Fluid 0̆3b1-Synuclein in Parkinson's Disease Is Associated with Disease Progression and Cognitive Decline

MLA

Emdina, Anna, et al. Baseline Cerebrospinal Fluid 0̆3b1-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline. Nov. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od.......518..a948401f7b745def9a1ec1131f440b3f&authtype=sso&custid=ns315887.

APA

Emdina, A., Hermann, P., Varges, D., Nuhn, S., Goebel, S., Bunck, T., Maass, F., Schmitz, M., Llorens, F., Kruse, N., Lingor, P., Mollenhauer, B., & Zerr, I. (2021). Baseline Cerebrospinal Fluid 0̆3b1-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline.

Chicago

Emdina, Anna, Peter Hermann, Daniela Varges, Sabine Nuhn, Stefan Goebel, Timothy Bunck, Fabian Maass, et al. 2021. “Baseline Cerebrospinal Fluid 0̆3b1-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline,” November. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od.......518..a948401f7b745def9a1ec1131f440b3f&authtype=sso&custid=ns315887.